Nasdaq:US$15.81 (+0.12) | HKEX:HK$24.45 (-0.75) | AIM:£2.30 (+0.09)
搜索结果
上一篇文章   |   下一篇文章
公告及新闻稿, 肿瘤学 / 免疫学 | 2006-07-04

Chi-Med plans to broaden clinical trials of its leading oncology drug candidate